Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Argiris, Athanassios
Item TypeName
Concept Lung Neoplasms
Academic Article A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
Academic Article Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.
Academic Article Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.
Academic Article Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer.
Academic Article A phase I study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer.
Academic Article Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
Academic Article Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.
Academic Article A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
Academic Article Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story.
Academic Article Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.
Academic Article Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas.
Academic Article A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.
Academic Article Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study.
Academic Article The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib.
Academic Article PET scan assessment of chemotherapy response in metastatic paraganglioma.
Academic Article Progress in the therapy of small cell lung cancer.
Academic Article A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
Academic Article Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Academic Article Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer.
Academic Article Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go.
Academic Article Can current treatments for advanced non-small-cell lung cancer be improved?
Academic Article Induction chemotherapy for resectable non-small-cell lung cancer.
Academic Article Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer.
Academic Article Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.
Academic Article Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer.
Academic Article Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
Academic Article A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
Search Criteria
  • Lung Neoplasms